I think what is useful about the FDA regulatory aspects of medical devices is that once your device class and required documents/steps are determined, there is a relatively clear pathway that your team must follow for FDA approval. Of course, I imagine that in medical device development, the FDA guidelines provide a stricter timeline that the team must adhere to, even if it may take longer than what the customer/shareholders would like. It seems likely that having to balance the normal customer and shareholder expectations of an engineering project with working within the FDA's regulatory pathway may cause some stress when it comes to creating a WBS. Involving cross-functional teams in the WBS creation will help ensure that realistic task expectations are set and things are not overlooked. I have not had experience with WBS creation myself, so these are just my guesses.

An essential difference when it comes to constructing a WBS for medical devices is that it should be built around regulatory readiness as an ongoing process instead of a final step. In a general engineering project, compliance and testing usually happen when a product is almost complete. Yet, in medical device development, it should occur in tandem with the design and development. Therefore, the WBS should include assignments that support iterative review processes, documentation changes, and traceability in a lifecycle, not simply technical milestones. Also, there can be missed opportunities for risk mitigation, like discovering compliance gaps late in a project timeline, which can be higher in costs. Integrating activities early will allow the WBS to become an essential tool that can support regulatory approval and innovation. Along with involving cross functional teams to strengthen WBS, it is essential to have various perspectives for a product's lifecycle; addressing features such as patient safety, manufacturability, and more can be effective. Collaboration can improve risk management by targeting issues early when they can be less expensive and smoother to tackle. It is best practice to have review checkpoints and functional objectives when it comes to deliverables in a WBS. It is also important to question how a team can truly balance and develop a detailed WBS to ensure compliance and at the same time avoid making it too complex, which can slow down a project's performance?

The WBS is arguably the backbone of any project plan, but in medical device development it carries greater weight than a typical engineering project. In a regular engineering project, you are primarily dealing with technical deliverables and business milestones. With medical device development like you mentioned, you are layering regulatory compliance on top of everything else typically involved in an engineering project timeline. Every phase of development has to map not just what the team and shareholders are expecting to build, but also what the FDA expects to see documented, tested, and submitted. This means that design controls, risk management activities, verification and validation planning, and 510K or PMA submission preparations all need to be reflected in the WBS from start to finish, and must be thoroughly embedded within it. 

Then to your question of cross-functional brainstorming, I find that this is one of the best methods to improve the outcome of any project, not just one related to the development of medical devices. By introducing other teams who all may have varying scopes of responsibilities within the development of the project, you can greatly reduce any oversight by introducing these new perspectives. For example, if you only have the engineers build the WBS, it would be technically complete in structure, and would explain technical requirements really well, but would be missing things such as labelling requirements, post market surveillance planning, clinical and human factors and even regular regulatory affairs. By introducing other teams to meet and share perspectives, the WBS would become more complete and actually address all of the aspects that it would need to be fully complete. 

The construction of a Work Breakdown Structure (WBS) in medical device development differs significantly from general engineering projects because it must integrate not only technical and commercial objectives but also strict regulatory and quality requirements imposed by the U.S. Food and Drug Administration and standards such as ISO 13485 and ISO 14971. Unlike general engineering projects that may focus primarily on design, development, and deployment, medical device WBS structures must include formal design controls, verification and validation activities, risk management documentation, regulatory submissions (such as 510(k) or PMA), and post-market surveillance planning. This makes the WBS more documentation-driven, risk-oriented, and traceability-focused. Involving cross-functional teams in the brainstorming process significantly improves planning and risk management because regulatory, quality, clinical, manufacturing, and engineering perspectives help identify hidden dependencies and compliance gaps early in development. For example, regulatory specialists may highlight additional testing requirements, while quality teams ensure proper documentation and traceability from user requirements through validation. This collaborative approach reduces the likelihood of costly rework, regulatory delays, and patient safety risks, making the WBS not just a scheduling tool but a foundational compliance and risk management framework in medical device development.

I agree that one of the biggest differences in a medical device WBS is how deeply regulatory requirements are embedded from the start. In general engineering projects, compliance can sometimes feel like a final checkpoint. In medical devices, it has to run in parallel with design the entire time. That changes how the WBS is structured. It becomes more documentation-driven and traceability-focused, not just milestone-based.

I also think cross-functional brainstorming is especially important in this space. If only engineers build the WBS, it may cover technical tasks well but miss things like labeling reviews, human factors studies, post-market surveillance planning, or quality documentation updates. Bringing in regulatory, quality, clinical, and manufacturing teams early helps surface those hidden tasks before they become late-stage surprises.

Overall, a medical device WBS is less about listing what to build and more about mapping how to prove safety, effectiveness, and compliance at every stage. That mindset shift is what really separates it from a typical engineering project.